Cargando…
Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer Disease
Individuals with Alzheimer Disease who develop psychotic symptoms (AD + P) experience more rapid cognitive decline and have reduced indices of synaptic integrity relative to those without psychosis (AD-P). We sought to determine whether the postsynaptic density (PSD) proteome is altered in AD + P re...
Autores principales: | Krivinko, J. M., DeChellis-Marks, M. R., Zeng, L., Fan, P., Lopez, O. L., Ding, Y., Wang, L., Kofler, J., MacDonald, M. L., Sweet, R. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238472/ https://www.ncbi.nlm.nih.gov/pubmed/37268664 http://dx.doi.org/10.1038/s42003-023-04961-5 |
Ejemplares similares
-
Psychosis in Alzheimer's Disease Is Associated With Increased Excitatory Neuron Vulnerability and Post-transcriptional Mechanisms Altering Synaptic Protein Levels
por: DeChellis-Marks, Michael R., et al.
Publicado: (2022) -
Fingolimod mitigates synaptic deficits and psychosis‐like behavior in APP/PSEN1 mice
por: Krivinko, Josh M., et al.
Publicado: (2022) -
Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease
por: Fan, Peihao, et al.
Publicado: (2023) -
Superior Cluneal Neuralgia Treated With Wireless Peripheral Nerve Stimulation
por: Chauhan, Gaurav, et al.
Publicado: (2022) -
Genetic Risk for Schizophrenia and Psychosis in Alzheimer Disease
por: DeMichele-Sweet, Mary Ann A., et al.
Publicado: (2017)